www.my.calendars.net/wmi
Achtung: Zockeraktien - Totalverlust nicht ausgeschlossen !
auf Wunsch gerne nochmal 
http://seekingalpha.com/article/...n-coming-in-september?source=yahoo
kleiner Auszug:
A limited study involving insulin antibodies in subjects using Generex's (GNBT) Oral-lyn will be in the spotlight this September at the EASD Annual Meeting in Stockholm, Sweden.
oder:
Result trends are showing that Oral-lyn, comprised of human insulin and GRAS (Generally Regarded as Safe by the FDA) excipients, is more naturally accepted by the body and therefore does not result in insulin resistance. These results are preliminary, with a full analysis of the Type 1 Phase III study expected to be complete in early 2011, while three month results for all patients are expected much sooner.
d. h. diese Ergebnisse sind vorläufig, die komplette Analyse der Studie (Typ1 Phase III) wird im Frühjahr 2011 erwartet.
Gruß
Dude44
|